🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, prospective, single-arm, open-label phase II study...
Status
Completed
Location
Asan Medical Center
Start Date
2012-09
Trial ID
NCT01719549
Treatments Being Tested
Chronic kidney disease (CKD), is characterized by accelerated development o...
Status
Completed
Location
Poznan University of Medical Sciences
Start Date
2016-03-25
Trial ID
NCT05214872
Treatments Being Tested
This is an open-label, single arm study to study the safety, efficacy and t...
Status
Completed
Location
Valkyrie Clinical Trials
Start Date
2022-04-29
Trial ID
NCT05253807
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of le...
Status
Unknown
Location
Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Start Date
2012-04
Trial ID
NCT03315078
This trial is an open, phase II clinical study. The study is divided into t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-09-30
Trial ID
NCT05775874
Treatments Being Tested
The primary objective of this study is to determine the safety, tolerabilit...
Status
Completed
Location
USC Norris Hospital and Clinics
Start Date
2018-07-25
Trial ID
NCT03517956
Treatments Being Tested
This trial will assess the 6-month complete response rate and toxicity prof...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2013-03
Trial ID
NCT01732107
Treatments Being Tested
A 52 week, open label trial to assess the safety and efficacy of KRN23, an ...
Status
Completed
Location
The Focus Center, PC
Start Date
2018-01-31
Trial ID
NCT03581591
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173
This is a two center, open label, non-randomized Phase II study of lenvatin...
Status
Withdrawn
Location
University of California, San Diego
Start Date
2018-07-01
Trial ID
NCT02846766
Treatments Being Tested